yemenjmedYemen Journal of MedicinecoVolume 4 Issue 2MultidisciplinaryEnglishMay-August 2025NNY20250922ArticleCardiovascular Nanomedicines: A Review of Nanoparticle-Mediated Strategies for Disease TreatmentEnglishY204213KalyaniDhatadak1EnglishNPragatiBhalerao1EnglishYSakshiSoni1EnglishYManojkumarMahajan2EnglishYAmanUpaganlawar3EnglishYChandrashekharUpasani4EnglishY10.63475/yjm.v4i2.0016Worldwide, cardiovascular diseases (CVDs) are the leading cause of mortality, demanding innovative therapeutic strategies. Nanomedicine offers promising solutions through nanoparticle-mediated drug delivery, enhancing precision, efficacy, and safety. This review examines nanocarriers, including liposomes, polymeric nanoparticles, and dendrimers, for targeted CVD treatment, encompassing coronary artery disease, atherosclerosis, and myocardial infarction. This review highlights advances in theranostics, gene therapy, and stimuli-responsive systems while addressing challenges related to biocompatibility and clinical translation. Nanotechnology holds transformative potential for CVD management, enabling personalized and least invasive treatments.EnglishCardiovascular diseases, targeted drug delivery, nanoparticles, ischemic heart diseases, myocardial infarctionhttps://www.yemenjmed.com/admin/abstract?id=209References1619